From left: Eyal Shalmon, chairman of the board of Algaia; Antoine Velge, CEO & President of Sapec; Celia Hart, Managing Partner of SuperNova; Fabrice Bohin, CEO & founder of Algaia and Efrat Gilat, CEO of Maabarot.

Paris-based Algaia, S.A has announced the acquisition of about 31% of its shares by Sapec sgps and its controlling shareholder, the Velge family, by the purchasing of Demeter & Cap Decisif stakes. Maabarot Products Ltd, SuperNova Invest and Algaia management maintain their respective stockholding positions.

Algaia SA is a well-established global player in the field of specialty seaweed extracts benefiting from unique R&D and production capabilities. Last year, most of its revenues were generated in food, personal care and nutraceutical applications. Algaia owns a novel and proprietary technology allowing the biorefinery of brown algae not only into alginates, but also other valuable compounds such as biostimulants for the crop nutrition industry.

Algaia’s facility is strategically located in Britany (France) next to abundant renewable fresh brown seaweed biomass, enabling the company to get sustainable and reliable supply. Algaia is today the world largest buyer of French seaweed, with about 40,000 tons being transformed every year in its Lannilis facility.

“Algaia is uniquely positioned in the marine extract industry,” said Eyal Shalmon, Algaia’s Chairman of the Board. “The company benefits from outstanding, focused, R&D and production capabilities, able to co-extract multiple compounds out of the same natural marine raw material. Maabarot Products Ltd, SuperNova Invest and Algaia management are all very pleased to welcome Antoine Velge, CEO & President of Sapec, into the company’s board of directors.”

Since the divestiture in 2016 of its Agro Business (Sapec Agro and Tradecorp) to Bridgepoint (Private Equity firm) for an enterprise value of over 450 million Euros, Sapec’s shareholders successfully achieved a public repurchase process to make the group 100% privately owned. Since then, the company pursued a strategy to re-deploy its cash positions.

“Our investment in Algaia is part of an overall strategy to develop in businesses where we see significant growth opportunities,” said Mr. Velge. “Algae-based products correspond to multiple market demands, all looking for more natural and sustainable solutions. During the due diligence process we were impressed by Algaia’s vision, people, outstanding assets, innovation capabilities and execution drive. We share with Maabarot and SuperNova similar values and we are excited to start contributing to the company’s development.”

Details of the transaction were kept confidential.